Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.20+0.01 (+0.08%)
Close on Nov 18, 2026Market cap $136.43MP/E –Yield 0.00%
Medifast revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Medifast's revenue for the twelve months ending Sep 30, 2026 was $299.57M, down 30.3% year over year. For fiscal 2025 it was $385.79M, down 36.0% from the year before. Over ten years it grew 3.5% a year on average. The highest annual figure on record is $1.60B in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $385.79M | -36.0% |
| FY2024 | Dec 31, 2024 | $602.46M | -43.8% |
| FY2023 | Dec 31, 2023 | $1.07B | -32.9% |
| FY2022 | Dec 31, 2022 | $1.60B | +4.8% |
| FY2021 | Dec 31, 2021 | $1.53B | +63.2% |
| FY2020 | Dec 31, 2020 | $934.84M | +31.0% |
| FY2019 | Dec 31, 2019 | $713.67M | +42.4% |
| FY2018 | Dec 31, 2018 | $501.00M | +66.1% |
| FY2017 | Dec 31, 2017 | $301.56M | +9.8% |
| FY2016 | Dec 31, 2016 | $274.53M | +0.6% |
| FY2015 | Dec 31, 2015 | $272.77M | -4.4% |
| FY2014 | Dec 31, 2014 | $285.29M | -12.0% |
| FY2013 | Dec 31, 2013 | $324.05M | +1.7% |
| FY2012 | Dec 31, 2012 | $318.57M | +6.8% |
| FY2011 | Dec 31, 2011 | $298.19M | +15.8% |
| FY2010 | Dec 31, 2010 | $257.55M | +51.7% |
| FY2009 | Dec 31, 2009 | $169.74M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $72.05M | -19.4% |
| Q2 FY2026 | Jun 30, 2026 | $76.38M | -27.6% |
| Q1 FY2026 | Mar 31, 2026 | $76.04M | -34.3% |
| Q4 FY2025 | Dec 31, 2025 | $75.10M | -36.9% |
| Q3 FY2025 | Sep 30, 2025 | $89.41M | -36.2% |
| Q2 FY2025 | Jun 30, 2025 | $105.56M | -37.4% |
| Q1 FY2025 | Mar 31, 2025 | $115.73M | -33.8% |
| Q4 FY2024 | Dec 31, 2024 | $119.00M | -37.7% |
| Q3 FY2024 | Sep 30, 2024 | $140.16M | -40.6% |
| Q2 FY2024 | Jun 30, 2024 | $168.56M | -43.1% |
| Q1 FY2024 | Mar 31, 2024 | $174.74M | -49.9% |
| Q4 FY2023 | Dec 31, 2023 | $191.02M | -43.4% |
| Q3 FY2023 | Sep 30, 2023 | $235.87M | -39.6% |
| Q2 FY2023 | Jun 30, 2023 | $296.19M | -34.7% |
| Q1 FY2023 | Mar 31, 2023 | $348.98M | -16.4% |
| Q4 FY2022 | Dec 31, 2022 | $337.25M | -10.7% |
| Q3 FY2022 | Sep 30, 2022 | $390.40M | -5.6% |
| Q2 FY2022 | Jun 30, 2022 | $453.33M | +15.0% |
| Q1 FY2022 | Mar 31, 2022 | $417.60M | +22.6% |
| Q4 FY2021 | Dec 31, 2021 | $377.83M | +42.6% |
| Q3 FY2021 | Sep 30, 2021 | $413.40M | +52.3% |
| Q2 FY2021 | Jun 30, 2021 | $394.19M | +79.2% |
| Q1 FY2021 | Mar 31, 2021 | $340.67M | +90.9% |
| Q4 FY2020 | Dec 31, 2020 | $264.91M | +55.3% |
| Q3 FY2020 | Sep 30, 2020 | $271.47M | +42.8% |
| Q2 FY2020 | Jun 30, 2020 | $220.00M | +17.6% |
| Q1 FY2020 | Mar 31, 2020 | $178.46M | +7.6% |
| Q4 FY2019 | Dec 31, 2019 | $170.63M | +17.0% |
| Q3 FY2019 | Sep 30, 2019 | $190.06M | +36.5% |
| Q2 FY2019 | Jun 30, 2019 | $187.10M | +59.5% |
| Q1 FY2019 | Mar 31, 2019 | $165.88M | +68.2% |
| Q4 FY2018 | Dec 31, 2018 | $145.84M | +87.0% |
| Q3 FY2018 | Sep 30, 2018 | $139.24M | +80.3% |
| Q2 FY2018 | Jun 30, 2018 | $117.32M | +54.9% |
| Q1 FY2018 | Mar 31, 2018 | $98.60M | +39.6% |
| Q4 FY2017 | Dec 31, 2017 | $78.01M | +24.9% |
| Q3 FY2017 | Sep 30, 2017 | $77.21M | – |
| Q2 FY2017 | Jun 30, 2017 | $75.73M | – |
| Q1 FY2017 | Mar 31, 2017 | $70.62M | – |
| Q4 FY2016 | Dec 31, 2016 | $62.47M | – |
See a number that looks wrong?